Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7528143 Bi-aryl meta-pyrimidine inhibitors of kinases

Patent 7528143 was granted and assigned to Targegen, Inc. on May, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Joel Renick0

Daniel L. Lohse0

Glenn Noronha0

Jianguo Cao0

John D. Hood0

Richard M. Soll0

Ved P. Pathak0

Andrew McPherson0

...

Date of Patent

May 5, 2009

0

Patent Application Number

115886380

Date Filed

October 26, 2006

0

Patent Citations Received

US Patent 12091411 IRAK degraders and uses thereof

0

US Patent 11679109 SMARCA degraders and uses thereof

0

US Patent 11685750 Crystalline forms of IRAK degraders

0

US Patent 11707457 IRAK degraders and uses thereof

0

US Patent 11746120 Stat degraders and uses thereof

US Patent 11779578 IRAK degraders and uses thereof

US Patent 11819505 Heterocyclylamines as PI3K inhibitors

0

US Patent 11932635 CRBN ligands and uses thereof

0

...

Patent Primary Examiner

James O. Wilson

0

Patent abstract

The invention provides biaryl meta-pyrimidine compounds having the general structure (A). The pyrimidine compounds of the invention are capable of inhibiting kinases, such as members of the Jak kinase family, and various other specific receptor and non-receptor kinases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7528143 Bi-aryl meta-pyrimidine inhibitors of kinases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.